• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚(ADP - 核糖)合成酶抑制剂减轻猪心肌再灌注损伤

Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig.

作者信息

Bowes J, Ruetten H, Martorana P A, Stockhausen H, Thiemermann C

机构信息

The William Harvey Research Institute, St. Bartholomew's and The Royal London School of Medicine and Dentistry, UK.

出版信息

Eur J Pharmacol. 1998 Oct 23;359(2-3):143-50. doi: 10.1016/s0014-2999(98)00638-4.

DOI:10.1016/s0014-2999(98)00638-4
PMID:9832385
Abstract

The effect of the Poly (adenosine 5'-diphosphate ribose) synthetase (PARS) inhibitor 3-aminobenzamide on (i) infarct size caused by regional myocardial ischaemia (60 min) and reperfusion (3 h) in the anaesthetised pig, and (ii) on the cell injury/necrosis of human cardiomyoblasts caused by hydrogen peroxide (3 mM) was investigated. Regional myocardial ischaemia and reperfusion resulted in an infarct size of 66+/-3% of the area at risk, which was reduced by 3-aminobenzamide (to 44+/-2%, n=6), but not 3-aminobenzoic acid (66+/-5%, n=4). 3-aminobenzamide also reduced the postischaemic contractile dysfunction. 3-aminobenzamide, but not 3-aminobenzoic acid, abolished the increase in PARS activity as well as the cell injury/necrosis caused by hydrogen peroxide in the cardiomyoblasts. In conclusion, the PARS inhibitor 3-aminobenzamide reduces myocardial reperfusion injury in the pig, and attenuates the cell injury and death associated with oxidant stress in human cardiomyoblasts. We propose that the activation of PARS plays an important role in the injury associated with oxidant stress of the heart.

摘要

研究了聚(腺苷5'-二磷酸核糖)合成酶(PARS)抑制剂3-氨基苯甲酰胺对以下两方面的影响:(i)麻醉猪局部心肌缺血(60分钟)和再灌注(3小时)所致的梗死面积;(ii)过氧化氢(3 mM)所致的人成心肌细胞的细胞损伤/坏死。局部心肌缺血和再灌注导致梗死面积占危险区域面积的66±3%,3-氨基苯甲酰胺可使其减小(降至44±2%,n = 6),但3-氨基苯甲酸则无此作用(66±5%,n = 4)。3-氨基苯甲酰胺还减轻了缺血后的收缩功能障碍。3-氨基苯甲酰胺而非3-氨基苯甲酸消除了过氧化氢所致的成心肌细胞中PARS活性增加以及细胞损伤/坏死。总之,PARS抑制剂3-氨基苯甲酰胺可减轻猪的心肌再灌注损伤,并减轻人成心肌细胞中与氧化应激相关的细胞损伤和死亡。我们认为,PARS的激活在心脏氧化应激相关损伤中起重要作用。

相似文献

1
Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig.聚(ADP - 核糖)合成酶抑制剂减轻猪心肌再灌注损伤
Eur J Pharmacol. 1998 Oct 23;359(2-3):143-50. doi: 10.1016/s0014-2999(98)00638-4.
2
Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress.聚(ADP - 核糖)合成酶抑制剂可保护大鼠心肌细胞免受氧化应激损伤。
Cardiovasc Res. 1999 Jan;41(1):126-34. doi: 10.1016/s0008-6363(98)00221-1.
3
Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase.聚(ADP - 核糖)合成酶抑制剂3 - 氨基苯甲酰胺对心肌缺血及再灌注损伤的保护作用
Cardiovasc Res. 1997 Nov;36(2):205-15. doi: 10.1016/s0008-6363(97)00137-5.
4
Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase.啮齿动物的心肌缺血预处理依赖于多聚(ADP - 核糖)合成酶。
Mol Med. 2001 Jun;7(6):406-17.
5
Inhibitors of the activity of poly (ADP-ribose) synthetase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts.聚(ADP - 核糖)合成酶活性抑制剂可减少过氧化氢所致人心脏成肌细胞的死亡。
Br J Pharmacol. 1998 Aug;124(8):1760-6. doi: 10.1038/sj.bjp.0702009.
6
Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.3-氨基苯甲酰胺(一种聚(ADP-核糖)合成酶抑制剂)在大鼠内脏动脉闭塞和再灌注模型中的有益作用。
Br J Pharmacol. 1997 Jul;121(6):1065-74. doi: 10.1038/sj.bjp.0701234.
7
Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.缺血/再灌注损伤大鼠外周血白细胞和再灌注心肌组织中多聚(ADP-核糖)化的增加:3-氨基苯甲酰胺治疗的预防作用。
Shock. 2012 May;37(5):492-500. doi: 10.1097/SHK.0b013e31824989d7.
8
Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences.3-氨基苯甲酰胺对大鼠心肌梗死模型中多聚(ADP-核糖)聚合酶激活的抑制作用:长期形态学和功能后果
Br J Pharmacol. 2001 Aug;133(8):1424-30. doi: 10.1038/sj.bjp.0704185.
9
Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle.抑制聚(ADP核糖)合成酶的活性可减轻心脏和骨骼肌的缺血再灌注损伤。
Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):679-83. doi: 10.1073/pnas.94.2.679.
10
Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor.新型强效聚(ADP-核糖)合成酶抑制剂PJ34对心肌的保护作用
Ann Thorac Surg. 2002 Feb;73(2):575-81. doi: 10.1016/s0003-4975(01)03329-x.

引用本文的文献

1
Olaparib protects cardiomyocytes against oxidative stress and improves graft contractility during the early phase after heart transplantation in rats.奥拉帕利可保护心肌细胞免受氧化应激,并改善大鼠心脏移植后早期移植物的收缩性。
Br J Pharmacol. 2018 Jan;175(2):246-261. doi: 10.1111/bph.13983. Epub 2017 Oct 2.
2
Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP).过氧亚硝酸盐诱导的DNA损伤在人类疾病中的病理生理作用:特别关注聚(ADP-核糖)聚合酶(PARP)
Indian J Clin Biochem. 2015 Oct;30(4):368-85. doi: 10.1007/s12291-014-0475-8. Epub 2015 Jan 20.
3
Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.
PARP 抑制剂的治疗应用:抗癌治疗及其他。
Mol Aspects Med. 2013 Dec;34(6):1217-56. doi: 10.1016/j.mam.2013.01.006. Epub 2013 Jan 29.
4
A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial.一项随机、安慰剂对照试验,旨在评估在接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中,使用强效多聚(ADP-核糖)聚合酶抑制剂(INO-1001)的耐受性、安全性、药代动力学和药效学:TIMI 37 试验结果。
J Thromb Thrombolysis. 2009 May;27(4):359-64. doi: 10.1007/s11239-008-0230-1. Epub 2008 Jun 6.
5
Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.聚(ADP - 核糖)聚合酶1(PARP - 1)在心血管疾病中的作用:PARP抑制剂的治疗潜力
Cardiovasc Drug Rev. 2007 Fall;25(3):235-60. doi: 10.1111/j.1527-3466.2007.00018.x.
6
Hsp70 attenuates hypoxia/reoxygenation-induced activation of poly(ADP-ribose) synthetase in the nucleus of adult rat cardiomyocytes.热休克蛋白70减轻成年大鼠心肌细胞核中缺氧/复氧诱导的聚(ADP-核糖)合成酶的激活。
Mol Cell Biochem. 2003 Jun;248(1-2):149-55. doi: 10.1023/a:1024192403758.
7
Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences.3-氨基苯甲酰胺对大鼠心肌梗死模型中多聚(ADP-核糖)聚合酶激活的抑制作用:长期形态学和功能后果
Br J Pharmacol. 2001 Aug;133(8):1424-30. doi: 10.1038/sj.bjp.0704185.
8
Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission.由DNA链断裂基础激活的聚(ADP - 核糖基)化反映了谷氨酸 - 一氧化氮神经传递。
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1845-50. doi: 10.1073/pnas.97.4.1845.
9
Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes.聚(ADP - 核糖)聚合酶缺陷型小鼠可免受链脲佐菌素诱导的糖尿病影响。
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3059-64. doi: 10.1073/pnas.96.6.3059.